Welcome!

News Feed Item

The World Market for Immunoassays

NEW YORK, April 24, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The World Market for Immunoassays

http://www.reportlinker.com/p02076275/The-World-Market-for-Immunoassays.html

The immunoassay market is large and long-established, but at the same time highly competitive. Kalorama Information's newly published report, The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting new strategies and for new entrants to take market share.

Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of types of immunoassays are now used to measure proteins (including antibodies), hormones, drugs, and other analytes. Fully automated immunoassay systems are now found in clinical laboratories. Even though the field of immunoassays is now mature, companies have continued to develop new immunoassays and immunoassay instrument platforms to further improve the sensitivity of the assays, to make multiplexing possible, to miniaturize the platforms for point-of-care, and to identify and develop assays for novel biomarkers, thus further expanding the potential of immunoassays for the future.

As part of its analysis the report provides:

Trends and innovations, including miniaturization and multiplexed assays
Regional and Emerging Market Opportunities
Novel Biomarkers Detected by Immunoassays
Segments of the Immunoassay Market, by Location of the Testing
Segments of the Immunoassay Market by Analyte Category
Sales for 2012 and Projected to 2017
Profiles of Companies Currently marketing Immunoassays
Profiles of New Companies Entering This Market.
Exhaustive Segment Market Data

Market analysis in this report is broken out into several market segments.

For each segment, current market size, forecast to 2017 and a discussion of the market is included:

Lab-Based Immunoassays
POC Immunoassays
Blood Screening Immunoassays
Fertility/Pregnancy Immunoassays
Thyroid, Metabolic Immunoassays
Therapeutic Drug Monitoring
Drugs of Abuse
Allergy Immunoassays
Autoimmune Immunoassays
PSA Markers
CEA Markers
CA 125 Markers
Other Tumor Markers
Hepatitis Immunoassays
HIV Immunoassays
STD Immunoassays
TORCH
Respiratory Immunoassays
Hospital Acquired Infection Immunoassays
Cardiac Markers
Other

The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.
CHAPTER ONE: EXECUTIVE SUMMARY:
Overview
Scope and Methodology
Market Overview
Future Prospects in the Immunoassay Market
CHAPTER TWO: INTRODUCTION
Background
History and Future of Immunoassays
CHAPTER THREE: TECHNOLOGY, TRENDS AND INNOVATIONS
Overview – Immunoassays
Overview – Instrument Platforms
Automation
Platform Innovations –
Miniaturization, Microfluidics and Multiplexed Assays
Specimen Types
Blood
Urine
Saliva
CHAPTER FOUR: MARKET SEGMENTS BY TYPE OF LABORATORY
Centralized Laboratories
Companies Marketing to Centralized Laboratories
Rapid and Point-of-Care Testing
POC Testing in Hospitals
Physicians' Office Laboratories and Clinics
Retail Clinics
Other Professional POC Testing
Self-Testing – Over-the-Counter (OTC) Tests
Companies Marketing Immunoassays for POC Testing
Blood Testing
CHAPTER FIVE: IMMUNOASSAY DIAGNOSTIC MARKET ACTIVITY BY DISEASE CATEGORY
Cardiac Markers
Fertility/Pregnancy/Reproductive Hormones
Thyroid
Metabolic Disorders and Other Hormones
Therapeutic Drug Monitoring
Drugs of Abuse
Allergy
Autoimmune Disease
Other Disease Categories in Immunoassay Disease Market
CHAPTER SIX: MARKET OPPORTUNITIES AND ISSUES FOR IMMUNOASSAYS
Immunoassay Market – Market Drivers and Changes
The Patient Protection and Affordable Care Act
Emerging International Markets
CHAPTER SEVEN: IMMUNOASSAY MARKET ANALYSIS
Market Overview and Market Segments by Type of Laboratory
Lab-Based Immunoassays by Disease Category
Point-of-Care/Rapid Test Immunoassays by Disease Category
Immunoassay Market in Different Geographical Regions
Prognosis for Growth of the Immunoassay Market
CHAPTER EIGHT: COMPANY PROFILES OF COMPANIES MARKETING IMMUNOASSAY SYSTEMS AND TESTS
1 Step Detect Associates, LLC
Abbott Laboratories
Recent Revenue History:
Access Bio, Inc.
AccuBioTech Co., Ltd
Accumed Biology (Shanghai) Co., Ltd.
Accutech, LLC
ACON Laboratories, Inc.
Advanced Biomedical Systems S.r.l. (ABS)
AESKU.DIAGNOSTICS
Akers Biosciences, Inc.
Alere Inc.
Recent Revenue History:
Alfa Scientific Designs, Inc.
ALPCO
Amedica Biotech
American Bio Medica Corporation
Recent Revenue History:
AmniSure International LLC (A Qiagen Company)
Ani Biotech Oy
Apacor Ltd.
ARK Diagnostics Inc
ARKRAY, Inc.
Arlington Scientific, Inc
Artron Laboratories Inc.
Associates of Cape Cod, Inc. (ACC)
Astra Biotech GmbH
Atlas Link, Inc.
Atlas Link Biotech Co., Ltd.
Audit Diagnostics
Augurix SA/Augurix Diagnostics
Autobio Diagnostics Co., Ltd.
Awareness Technology, Inc.
Avioq, Inc.
AXA Diagnostics Srl
Axis-Shield plc (Acquired by Alere)
Company Overview
AZOG, Inc.
Becton, Dickinson and Company (BD)
Beijing Chemclin Biotech Co., Ltd.
BG Medicine, Inc.
Bhat Bio-Tech India Private Ltd. (BBI)
Binding Site Group Ltd. (The)
Biocare Diagnostics Ltd.
BioCheck, Inc.
BIOCLIN
Biohit Oyj (BioHIt Healthcare)
Biokit S.A. (Part of Werfen Group)
bioLytical Laboratories Inc.
Bio-Medical Products Corp.
Biomerica, Inc.
Recent Revenue History
bioMérieux sa
BioPorto Diagnostics A/S
Recent Revenue History
Company Overview
Bio-Rad Laboratories, Inc.
Recent Revenue History
Company Overview
BioScan Screening Systems, Inc.
Bioscience (Tianjin) Diagnostic Technology Co., Ltd.
BioSino Bio-Technology and Science Inc.
Biotech Atlantic, Inc.
Biotron Diagnostics Inc.
Blue Cross Bio-medical Co., Ltd.
BNTX Inc.
Boditech Med Inc.
Boson Biotech Co., Ltd.
Branan Medical Corporation
BÜHLMANN Laboratories AG
Calypte Biomedical Corporation
CARE Diagnostica
CARE Products, Inc.
Cavida AB
CerTest Biotec
Chembio Diagnostics, Inc.
Recent Revenue History
Company Overview
Chemtron Biotech, Inc
Cisbio Bioassays
Clarity Diagnostics (Diagnostic Test Group, LLC)
Clinical Innovations, LLC
CONCATENO (Subsidiary of Alere)
Confirm Biosciences
ContraVac, Inc.
Core Technology Co., Ltd.
Corgenix Medical Corporation
Recent Revenue History
Company Overview
Coris BioConcept
CTK Biotech, Inc.
Denka Seiken Co., Ltd.
Devon Medical Products
DFI Co., Ltd
diaDexus, Inc.
Company Overview
Diagenics International Corporation
Diagnosticum Inc.
DIALAB GmbH
Diametra
DiaSorin S.p.A.
Recent Revenue History
Company Overview
DIAsource ImmunoAssays
DiaSys Diagnostic Systems
Diaxonhit
Diazyme Laboratories
DIESSE Diagnostica Senese S.p.A
Dr. Fooke Laboratorien GmbH
DRG International, Inc.
D-tek s.a.
Eiken Chemical Co., Ltd.
EKF Diagnostics Holdings plc
Recent Revenue History
Company Overview
Embryotech Laboratories
ERBA Diagnostics, Inc.
Recent Revenue History
Company Overview
Euroimmun AG
Eurospital Spa
EY Laboratories, Inc.
First Check Diagnostics Corp. (Subsidiary of Alere)
Focus Diagnostics, Inc. (Subsidiary of Quest Diagnostics Inc.)
Fujirebio Inc.
Recent Revenue History
Company Overview
Germaine Laboratories
GlysBy
Gold Standard Diagnostics Corporation
Grifols International S.A.
Company Overview
Hema Diagnostic Systems, LLC (HDS)
Hemosure, Inc.
Hightop Biotech Co., Ltd
Hipro Biotechnology Co., Ltd.
HYCOR Biomedical, Inc.
IDenta Corporation
IMMCO Diagnostics, Inc. (Acquired by Trinity Biotech)
Immunetics, Inc.
Immunodiagnostic Systems Ltd. (IDS)
Recent Revenue History
Company Overview
Immunomedics, Inc
Immuno-Mycologics, Inc.
ImmunoScience, Inc.
Immunostics, Inc.
InBios International, Inc.
INOVA Diagnostics, Inc. (Part of Werfen Group S.A.)
Instant Technologies, Inc
InTec Products, Inc.
International Immuno-Diagnostics
Jant Pharmacal Corporation
Jei Daniel Biotech Corp.
j. Mitra & Co.Pvt. Ltd.
Kronus
Lab 21 Limited
Labor Diagnostika Nord GMBH & CO. KG
Labsystems Diagnostics Group
Labtest
Lepu Medical Technology (Beijing) Co. Ltd.
LifeAssays AB
LifeSign LLC
Liming Bio-Products Co., Ltd
Luminex Corporation
Recent Revenue History
Company Overview
MagnaBioSciences, LLC
MAVAND Solutions GmbH
Medipan GmbH
Medisensor, Inc.
Mediwatch Plc
Medix Biochemica
Recent Revenue History
Mercodia AB
Recent Revenue History
Micropoint Bioscience, Inc.
Mitsubishi Chemical Medience Corporation
Monobind Inc.
MP Biomedicals, LLC
Nano-Ditech Corporation
Nantong Egens Biotechnology Co., Ltd.
National Test Systems (Formerly QuikTest USA, Inc.)
NewScen Coast Bio-Pharmaceutical Co., Ltd.
NexScreen LLC
Nobel Medical Inc.
Novatec Immundiagnostica GmbH
Oasis Diagnostics Corporation
Omega Diagnostics Group PLC
Oncimmune Ltd.
Operon
OraSure Technologies, Inc.
Recent Revenue History
Company Overview
Orgentec Diagnostika GmbH
Ortho-Clinical Diagnostics
Recent Revenue History
Company Overview
Pan Probe Biotech, Inc.
Perfemed Group
Pharmatech, Inc.
Pointe Scientific, Inc.
Polymedco, Inc.
Polymed Therapeutics, Inc.
Precheck Bio, Inc.
Prestige Diagnostics
Preventis GmbH
Princeton Biomeditech Corporation
Pro-Lab Diagnostics Inc.
Qualigen, Inc.
Recent Revenue History
Company Overview
Radiometer Medical ApS
Recent Revenue History
Company Overview
Randox Laboratories Ltd
Rapid Pathogen Screening, Inc.
R-Biopharm AG
Reagena Group
Real World Diagnostics
Redwood Toxicology Laboratory, Inc.
ReLIA Diagnostics, Inc.
RENESA UG
Response Biomedical Corporation
Recent Revenue History
Company Overview
Reszon Diagnostics International Sdn. Bhd.
Roche Diagnostics
Recent Revenue History
Company Overview
SA Scientific
Savyon Diagnostics
ScheBo-Biotech AG
Screening Devices Canada, Inc.
Sekisui Diagnostics, LLC
Serascience
Shanghai Kehua Bio-engineering Co., Ltd.
Shanghai Upper Biotech
Sichuan Maker Biotechnology Co., Ltd.
Company Overview
(Shenzhen New Industries Biomedical Engineering Co., Ltd.)
Span Diagnostics Ltd.
Standard Diagnostics (Part of Alere)
SureScreen Diagnostics
Syntron Bioresearch, Inc.
Systagenix Wound Management
TECHLAB, Inc.
Teco Diagnostics
Theradiag
Company Overview
Bio-Enoche Group, LLC
Tosoh Corporation
Company Overview
Transasia Bio-Medicals Ltd.
Trinity Biotech plc
True Diagnostics, Inc.
Turklab Medical Devices Inc.
UCP Biosciences, Inc.
US Diagnostics, Inc.
VEDA.LAB SA
Vircell S.L.
Vital Diagnostics, Inc. (An ELITech Group Company)
Recent Revenue History
Company Overview
Wako Diagnostics
WAMA Diagnostica
Werfen Group
Recent Revenue History
Company Overview
Wiener Laboratorios S.A.I.C.
Zhuhai Encode Medical Engineering Co., Ltd.
ZEUS Scientific, Inc.
CHAPTER NINE: NEW ENTRANTS
Akrivis Technologies, LLC
Alverix, Inc.
Amorfix Life Sciences Ltd.
Arbor Vita Corporation
Athera Biotechnologies
Atlas Genetics Ltd
Atonomics A/S
Augurex Life Sciences Corp.
Avant Diagnostics, Inc.
Axela, Inc.
AXO Science
Banyan Biomarkers
Biocartis SA
BioMedomics
BioMosaics
Biophor Diagnostics
Biosensia Ltd.
BioSystems International
Boulder Diagnostics
CardioGenics Holdings, Inc.
CD Diagnostics, Inc.
Cellmid Ltd.
Clearbridge BioLoc Pte Ltd.
Courtagen Life Sciences, Inc.
Crescendo Bioscience
Critical Diagnostics
Cytonics Corporation
CyVek Inc.
EDP Biotech Corporation
Endeavor Power Corp.
Epinex Diagnostics, Inc.
Epocal, Inc.
Eveia Medical, Inc.
Gamma Therapeutics, Inc.
Genalyte, Inc.
GeneFluidics, Inc
Genisphere, LLC
Gentag, Inc
HealthLinx Limited
ImCare BioTech
Innovative Health Diagnostics
Intrinsic LifeSciences
MagArray, Inc.
Magnisense SE
Martell Diagnostic Laboratories, Inc.
MBio Diagnostics, Inc.
Nanomix, Inc.
Ohmx Corporation
O-J-Bio Ltd.
OncoHealth Corporation
OPKU Health, Inc./OPKU Diagnostics
Protagen AG
Quanterix Corporation
Siloam Biosciences, Inc.
Singulex, Inc.
SQi Diagnostics Inc.
STAT-Diagnostica
Sword Diagnostics
T2 Biosystems, Inc.
Venaxis, Inc.
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1: Immunoassay Sales
Table 1-1: Immunoassay Sales (Lab-Based, POC, Blood Screening)
Figure 1-1: Immunoassay Sales Trend By Type (Lab Based, POC, Blood Screening)
CHAPTER THREE: TECHNOLOGY, TRENDS AND INNOVATIONS
Table 3-1: Selected Innovations in Immunoassay Platforms
Table 3-2: Selected Companies with Saliva or Oral-Fluid Collection Devices
CHAPTER FOUR: MARKET SEGMENTS BY TYPE OF LABORATORY
Table 4-1: Selected Companies Marketing Central Lab-Based Immunoassays
Table 4-2: Selected Companies Marketing Immunoassays and/or Lateral Flow Tests for Point-of-Care Testing
Table 4-3: Selected Companies Marketing Immunoassay Platforms for Blood Screening
CHAPTER FIVE: MARKET SEGMENTS BY TYPE OF LABORATORY
Table 5-1: Immunoassay Market Disease Categories
Table 5-2: Selected Infectious Disease Immunoassays
Table 5-3: Selected Companies Marketing Immunoassays for Infectious Diseases
Table 5-4: Selected Tumor Marker Immunoassays
Table 5-5: Selected Companies Marketing Immunoassays for Tumor Markers
Table 5-6: Selected Cardiac Marker Immunoassays
Table 5-7: Selected Companies Marketing Immunoassays for Cardiac Markers
Table 5-8: Selected Fertility and Reproductive Hormone Immunoassays
Table 5-9: Selected Companies Marketing Immunoassays Fertility/Pregnancy/Reproductive Hormone Diagnostics
Table 5-10: Selected Thyroid Immunoassays
Table 5-11: Selected Companies Marketing Immunoassays for Thyroid Diagnostics
Table 5-12: Selected Metabolic and Other Hormone Immunoassays
Table 5-13: Selected Companies Marketing Immunoassays for Metabolic/Other (Non-Reproductive, Non-Thyroid) Hormone Diagnostics
Table 5-14: Selected Therapeutic Drug Monitoring Immunoassays
Table 5-15: Selected Companies Marketing Immunoassays for Therapeutic Drug Monitoring
Table 5-16: Selected Drugs of Abuse Assays
Table 5-17: Selected Companies Marketing Immunoassays for Drugs of Abuse
Table 5-18: Selected Allergy Diagnostic Tests
Table 5-19: Selected Companies Marketing Immunoassays for Allergy Diagnostics
CHAPTER SEVEN: MARKET OPPORTUNITIES AND ISSUES FOR IMMUNOASSAYS
Table 7-1: Immunoassay Sales by Type of Laboratory Worldwide, 2012 and 2017 (Lab-Based, OTC, Prof. POC, Blood Screening)
Table 7-2: Revenue History of Leading Immunoassay Vendors*, 2010-2012
Table 7-3: Lab-Based Immunoassay Sales by Disease Category (Infectious Disease, Tumor Markers, Cardiac Markers, Fertility/Pregnancy, Thyroid, Metabolic, Therapeutic Drug Monitoring, Drugs of Abuse, Allergy, Autoimmune, Other) Worldwide, 2012 and 2017
Table 7-4: Lab-Based Infectious Disease Immunoassay Sales Worldwide, 2012 (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other)
Table 7-5: Lab-Based Tumor Marker Immunoassay Sales Worldwide, 2012 (PSA, CEA, CA 125, AFP, Other)
Table 7-6: Point-of-Care/Rapid Immunoassay Sales by Disease Category (Pregnancy, Infectious Disease, Cancer, Cardiac Markers, Drugs of Abuse, Other) Worldwide, 2012 and 2017
Table 7-7: Immunoassay Sales by Geographic Region (North America, Europe, Japan, Rest of World) Worldwide, 2012 and 2017

To order this report: The World Market for Immunoassays
http://www.reportlinker.com/p02076275/The-World-Market-for-Immunoassays.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
One of the hottest areas in cloud right now is DRaaS and related offerings. In his session at 16th Cloud Expo, Dale Levesque, Disaster Recovery Product Manager with Windstream's Cloud and Data Center Marketing team, will discuss the benefits of the cloud model, which far outweigh the traditional approach, and how enterprises need to ensure that their needs are properly being met.
Containers have changed the mind of IT in DevOps. They enable developers to work with dev, test, stage and production environments identically. Containers provide the right abstraction for microservices and many cloud platforms have integrated them into deployment pipelines. DevOps and Containers together help companies to achieve their business goals faster and more effectively. In his session at DevOps Summit, Ruslan Synytsky, CEO and Co-founder of Jelastic, reviewed the current landscape of D...
In 2014, Amazon announced a new form of compute called Lambda. We didn't know it at the time, but this represented a fundamental shift in what we expect from cloud computing. Now, all of the major cloud computing vendors want to take part in this disruptive technology. In his session at 20th Cloud Expo, John Jelinek IV, a web developer at Linux Academy, will discuss why major players like AWS, Microsoft Azure, IBM Bluemix, and Google Cloud Platform are all trying to sidestep VMs and containers...
The many IoT deployments around the world are busy integrating smart devices and sensors into their enterprise IT infrastructures. Yet all of this technology – and there are an amazing number of choices – is of no use without the software to gather, communicate, and analyze the new data flows. Without software, there is no IT. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, Dave McCarthy, Director of Products at Bsquare Corporation; Alan Williamson, Principal ...
IoT is at the core or many Digital Transformation initiatives with the goal of re-inventing a company's business model. We all agree that collecting relevant IoT data will result in massive amounts of data needing to be stored. However, with the rapid development of IoT devices and ongoing business model transformation, we are not able to predict the volume and growth of IoT data. And with the lack of IoT history, traditional methods of IT and infrastructure planning based on the past do not app...
DevOps and microservices are permeating software engineering teams broadly, whether these teams are in pure software shops but happen to run a business, such Uber and Airbnb, or in companies that rely heavily on software to run more traditional business, such as financial firms or high-end manufacturers. Microservices and DevOps have created software development and therefore business speed and agility benefits, but they have also created problems; specifically, they have created software securi...
WebRTC has had a real tough three or four years, and so have those working with it. Only a few short years ago, the development world were excited about WebRTC and proclaiming how awesome it was. You might have played with the technology a couple of years ago, only to find the extra infrastructure requirements were painful to implement and poorly documented. This probably left a bitter taste in your mouth, especially when things went wrong.
"There is a huge interest in Kubernetes. People are now starting to use Kubernetes and implement it," stated Sebastian Scheele, co-founder of Loodse, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Media announced today that @WebRTCSummit Blog, the largest WebRTC resource in the world, has been launched. @WebRTCSummit Blog offers top articles, news stories, and blog posts from the world's well-known experts and guarantees better exposure for its authors than any other publication. @WebRTCSummit Blog can be bookmarked ▸ Here @WebRTCSummit conference site can be bookmarked ▸ Here
A critical component of any IoT project is what to do with all the data being generated. This data needs to be captured, processed, structured, and stored in a way to facilitate different kinds of queries. Traditional data warehouse and analytical systems are mature technologies that can be used to handle certain kinds of queries, but they are not always well suited to many problems, particularly when there is a need for real-time insights.
Providing secure, mobile access to sensitive data sets is a critical element in realizing the full potential of cloud computing. However, large data caches remain inaccessible to edge devices for reasons of security, size, format or limited viewing capabilities. Medical imaging, computer aided design and seismic interpretation are just a few examples of industries facing this challenge. Rather than fighting for incremental gains by pulling these datasets to edge devices, we need to embrace the i...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
In his session at DevOps Summit, Tapabrata Pal, Director of Enterprise Architecture at Capital One, will tell a story about how Capital One has embraced Agile and DevOps Security practices across the Enterprise – driven by Enterprise Architecture; bringing in Development, Operations and Information Security organizations together. Capital Ones DevOpsSec practice is based upon three "pillars" – Shift-Left, Automate Everything, Dashboard Everything. Within about three years, from 100% waterfall, C...
Fifty billion connected devices and still no winning protocols standards. HTTP, WebSockets, MQTT, and CoAP seem to be leading in the IoT protocol race at the moment but many more protocols are getting introduced on a regular basis. Each protocol has its pros and cons depending on the nature of the communications. Does there really need to be only one protocol to rule them all? Of course not. In his session at @ThingsExpo, Chris Matthieu, co-founder and CTO of Octoblu, walked through how Octob...